OTTAWA, March 17 /CNW Telbec/ - The Conference Board of Canada and the
Canadian Health Industries Partnership (CHIP) have reached an agreement to
jointly create the Centre for the Advancement of Health Innovations (CAHI).
The new centre will build on the resources, talent, and commitment of the
Conference Board and CHIP to make Canada a world leader in the development and
commercialization of health innovations.
CAHI will adopt a global perspective in identifying and exploring the
applicability of best practices to Canada and Canadian industries. To this
end, the centre will have an International Advisory Panel chaired by Henry
Friesen, founding president of the Canadian Institute of Health Research and
founder of CHIP. This panel will be made up of world leaders in health
innovation who bring with them a vast wealth of experience and knowledge. The
inaugural meeting of this policy centre will take place on March 31-April 1,
2008 in Toronto.
The co-chairs are Dr. Calvin Stiller, Chair of Genome Canada and Mark
Lievonen, President of Sanofi Pasteur Limited and Chair of CHIP.
The Conference Board of Canada (CBoC) is widely recognized as Canada's
foremost independent, not-for-profit research organization specializing in
economic trends, public policy, and organizational performance.
The Canadian Health Industries Partnership (CHIP) is a legally
constituted not-for-profit organization that provides a forum to enable
governments, academia, and leaders of Canada's industrial health innovation
sector to collaborate in exchanging perspectives, discussing and developing
recommended strategy directions and policy options on health innovation.
For more information, visit www.conferenceboard.ca/CAHI
For further information:
For further information: Brent Dowdall, Media Relations, (613) 526-3090
ext. 448, email@example.com